alpha-aminopyridine has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, YL; Chen, CY; Chen, SN; Du, X; Guo, JX; Han, YQ; Hu, JD; Huang, J; Jiang, Q; Li, F; Li, GH; Li, WM; Liang, R; Lin, H; Lin, LE; Liu, BC; Liu, CS; Liu, XL; Liu, ZF; Liu, ZG; Liu, ZL; Meng, L; Pan, L; Pang, LP; Qiu, HY; Sun, H; Sun, XL; Suo, XH; Tu, CQ; Wang, DY; Wang, XD; Xu, N; Yang, LJ; Yang, W; Yang, YF; Zeng, QS; Zhang, WH; Zhang, XS; Zhang, YL; Zhang, YQ; Zhao, ZY; Zheng, CF; Zheng, YJ; Zhou, L; Zhou, ZP; Zhu, HL | 1 |
1 other study(ies) available for alpha-aminopyridine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia].
Topics: Adolescent; Adult; Aminopyridines; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Treatment Outcome | 2023 |